Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8722857 Anti-CD79B antibodies and immunoconjugates and methods of use

Patent 8722857 was granted and assigned to Genentech on May, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 26 Jun, 2024

"update inverses"

edited on 26 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12016842 Methods of using anti-CD79b immunoconjugates

0

Edits on 29 Mar, 2024

"update inverses"

edited on 29 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11938194 Cysteine mutated antibodies for conjugation

0

Edits on 12 Jan, 2024

"update inverses"

edited on 12 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use

0

Edits on 2 Dec, 2023

"Add patent abstract"

edited on 2 Dec, 2023

Edits made to:

Article (+266 characters)

Article

Patent abstract

The present invention is directed to cysteine-engineered anti-CD79b antibody, huMA79b.v28, and compositions of matter thereof useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Edits on 25 Sep, 2023

"Add patent inventor(s)"

edited on 25 Sep, 2023

Edits made to:

Infobox (+6 properties)

Infobox

Patent Inventor Names

Andrew Polson0

David Dornan0

Jagath Reddy Junutula0

Kristi Elkins0

Mark Dennis0

Yvonne Chen0

Edits on 5 Jul, 2023

"update inverses"

edited on 5 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11692041 Antibody molecules which bind CD45

0

Edits on 21 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 21 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=087228570

"Remove leading 0 from patent number"

edited on 21 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 08722857 Anti-CD79B antibodies and immunoconjugates and methods of use US Patent 8722857 Anti-CD79B antibodies and immunoconjugates and methods of use

Infobox

Patent Number

087228570

Patent Number

87228570

Edits on 28 Sep, 2022

"Entity importer update"

edited on 28 Sep, 2022

Infobox

Is a

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

087228570

Date of Patent

May 13, 2014

0

Patent Application Number

123539170

Date Filed

January 14, 2009

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=087228570

Patent Primary Examiner

0

Edits on 19 Jun, 2022

"Entity importer update"

edited on 19 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=08722857

Edits on 23 Dec, 2021

"Created via: Entity Importer"

created this topic on 23 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 08722857 Anti-CD79B antibodies and immunoconjugates and methods of use

Infobox

Is a

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

08722857

Date of patent

May 13, 2014

Patent application number

12353917

Date Filed

January 14, 2009

Patent primary examiner

Find more entities like US Patent 8722857 Anti-CD79B antibodies and immunoconjugates and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.